179 related articles for article (PubMed ID: 1778851)
1. Role of OmpD2 and chromosomal beta-lactamase in carbapenem resistance in clinical isolates of Pseudomonas aeruginosa.
Satake S; Yoneyama H; Nakae T
J Antimicrob Chemother; 1991 Aug; 28(2):199-207. PubMed ID: 1778851
[TBL] [Abstract][Full Text] [Related]
2. Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa.
Livermore DM
Antimicrob Agents Chemother; 1992 Sep; 36(9):2046-8. PubMed ID: 1329641
[TBL] [Abstract][Full Text] [Related]
3. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
Livermore DM; Yang YJ
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
Chen HY; Livermore DM
J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
[TBL] [Abstract][Full Text] [Related]
5. Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase.
Minami S; Akama M; Araki H; Watanabe Y; Narita H; Iyobe S; Mitsuhashi S
J Antimicrob Chemother; 1996 Mar; 37(3):433-44. PubMed ID: 9182100
[TBL] [Abstract][Full Text] [Related]
6. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
Cho HH; Kwon GC; Kim S; Koo SH
J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of imipenem resistance acquired by three Pseudomonas aeruginosa strains during imipenem therapy.
Vurma-Rapp U; Kayser FH; Hadorn K; Wiederkehr F
Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):580-7. PubMed ID: 2120059
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S
Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099
[TBL] [Abstract][Full Text] [Related]
9. Response of chemostat cultures of Pseudomonas aeruginosa to carbapenems and other beta-lactams.
Wu PJ; Livermore DM
J Antimicrob Chemother; 1990 Jun; 25(6):891-902. PubMed ID: 2115037
[TBL] [Abstract][Full Text] [Related]
10. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
Martínez-Beltrán J; Calderón C; Sierra MP; Alvarez M; Cantón R
Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373200
[TBL] [Abstract][Full Text] [Related]
12. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
Lee JY; Ko KS
Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
[TBL] [Abstract][Full Text] [Related]
13. Imipenem and meropenem induced resistance to beta-lactam antibiotics in Pseudomonas aeruginosa.
Giacometti A; Siquini FM; Cirioni O; Petroni S; Scalise G
Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):315-8. PubMed ID: 8070438
[TBL] [Abstract][Full Text] [Related]
14. Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream.
Najar Peerayeh S; Pirhajati Mahabadi R; Pakbaten Toupkanlou S; Siadat SD
Burns; 2014 Nov; 40(7):1360-4. PubMed ID: 24513132
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients.
Ballestero S; Fernández-Rodríguez A; Villaverde R; Escobar H; Pérez-Díaz JC; Baquero F
J Antimicrob Chemother; 1996 Jul; 38(1):39-45. PubMed ID: 8858455
[TBL] [Abstract][Full Text] [Related]
17. beta-Lactamase Id of ceftazidime-resistant Pseudomonas aeruginosa strains.
Michel-Briand Y; Nicolas T; Godard C; Plesiat P
Microbiologica; 1992 Jan; 15(1):65-9. PubMed ID: 1556960
[TBL] [Abstract][Full Text] [Related]
18. SPM-1-producing Pseudomonas aeruginosa ST277 clone recovered from microbiota of migratory birds.
Martins WMBS; Narciso AC; Cayô R; Santos SV; Fehlberg LCC; Ramos PL; da Cruz JB; Gales AC
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):221-227. PubMed ID: 29224710
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of beta-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey.
Bonfiglio G; Laksai Y; Franchino L; Amicosante G; Nicoletti G
J Antimicrob Chemother; 1998 Dec; 42(6):697-702. PubMed ID: 10052891
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
Hu YF; Liu CP; Wang NY; Shih SC
BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
